Literature DB >> 10638568

Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia?

H H Xia1, J S Kalantar, N J Talley, J M Wyatt, S Adams, K Chueng, H M Mitchell.   

Abstract

OBJECTIVES: Helicobacter pylori is a carcinogen; gastric carcinoma involves a multistep process from chronic gastritis to atrophy, intestinal metaplasia, and dysplasia. The aims of this study were to determine the types of mucosa at different gastric sites in H. pylori-infected and uninfected patients, and whether the presence of antral-type mucosa in the incisura, body, and fundus is associated with gastric atrophy and intestinal metaplasia.
METHODS: Two hundred and sixty-eight patients with dyspepsia were enrolled. Eight biopsies (i.e., antrum x3, body x2, fundus x2, and incisura x1) were obtained. One antral biopsy was used for the CLO-test. Three (each from the antrum, body, and fundus) were cultured. The remaining biopsies were examined histologically according to the updated Sydney System after staining with hematoxylin and eosin and Giemsa. A validated serological test was also applied.
RESULTS: Overall, 113 (42%) patients were infected with H. pylori. At the incisura, antral-type mucosa was more prevalent in infected than in uninfected patients (84% vs. 18%; odds ratio [OR] = 23.9, 95% confidence interval [CI] 12.5-45.8; p<0.001). Atrophic gastritis and intestinal metaplasia at the incisura was present in 19.5% and 13.3%, respectively, of infected, and 4.5% and 3.2%, respectively, of uninfected patients (both p<0.01). Moreover, atrophic gastritis at the incisura was associated with the presence of antral-type mucosa at the site (termed antralization); the prevalence of atrophic gastritis was 19.5% (24/123) in the presence of antralization, whereas the rate was 2.1% (3/145) without antralization (OR = 11.4, 95% CI 3.4-39.2; p<0.001). Similarly, at the incisura, 16.3% (20/123) of "antralized" cases and 1.4% (2/145) of "unantralized" cases had intestinal metaplasia (OR = 13.8, 95% CI, 3.2-60.7; p<0.001). The association between antralization at gastric body and fundus also appeared to be associated with atrophic gastritis and intestinal metaplasia at these sites.
CONCLUSIONS: Atrophic gastritis and intestinal metaplasia occurs predominantly at the gastric antrum and incisura with H. pylori infection. Antralization of the gastric incisura is a common event in H. pylori-infected patients, and appears to be associated with an increased risk of atrophic gastritis and intestinal metaplasia.

Entities:  

Mesh:

Year:  2000        PMID: 10638568     DOI: 10.1111/j.1572-0241.2000.01609.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  23 in total

1.  Atrophic gastritis: pathology and endoscopy in the reversibility assessment.

Authors:  M Rugge; M Cassaro; G Pennelli; G Leandro; F Di Mario; F Farinati
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

Review 2.  Oxyntic atrophy, metaplasia, and gastric cancer.

Authors:  James R Goldenring; Ki Taek Nam
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

3.  A follow-up study on the effect of Helicobacter pylori eradication on the severity of gastric histology.

Authors:  Barik A Salih; M Fatih Abasiyanik; Huseyin Saribasak; Osman Huten; Ersan Sander
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

Review 4.  Is intestinal metaplasia of the stomach reversible?

Authors:  M M Walker
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

Review 5.  Acid and the basis for cellular plasticity and reprogramming in gastric repair and cancer.

Authors:  José B Sáenz; Jason C Mills
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-02-21       Impact factor: 46.802

6.  The transcription factor MIST1 is a novel human gastric chief cell marker whose expression is lost in metaplasia, dysplasia, and carcinoma.

Authors:  Jochen K M Lennerz; Seok-Hyung Kim; Edward L Oates; Won Jae Huh; Jason M Doherty; Xiaolin Tian; Andrew J Bredemeyer; James R Goldenring; Gregory Y Lauwers; Young-Kee Shin; Jason C Mills
Journal:  Am J Pathol       Date:  2010-08-13       Impact factor: 4.307

7.  Serum pepsinogens as a predicator of the topography of intestinal metaplasia in patients with atrophic gastritis.

Authors:  Yoshihisa Urita; Kazuo Hike; Naotaka Torii; Yoshinori Kikuchi; Eiko Kanda; Masahiko Sasajima; Kazumasa Miki
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

8.  Aberrant epithelial expression of trefoil family factor 2 and mucin 6 in Helicobacter pylori infected gastric antrum, incisura, and body and its association with antralisation.

Authors:  H H-X Xia; Y Yang; S K Lam; W M Wong; S Y Leung; S T Yuen; G Elia; N A Wright; B C-Y Wong
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

9.  Detection of serum anti-Helicobacter pylori immunoglobulin G in patients with different digestive malignant tumors.

Authors:  Ke-Xia Wang; Xue-Feng Wang; Jiang-Long Peng; Yu-Bao Cui; Jian Wang; Chao-Pin Li
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

10.  Antralization of the gastric mucosa of the incisura angularis and its gastrin expression.

Authors:  Carlos A Rubio; Edgar Jaramillo; Gaku Suzuki; Pernilla Lagergren; Gabriella Nesi
Journal:  Int J Clin Exp Pathol       Date:  2008-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.